Author/Authors :
Nanjwadea, Basavaraj K. Department of Pharmaceutics, J. N. Medical College - KLE University, Nehru Nagar, Belgaum, Karnataka, India , Derkara, Ganesh K. Department of Pharmaceutics, J. N. Medical College - KLE University, Nehru Nagar, Belgaum, Karnataka, India , Bechraa, Hiren Department of Pharmaceutics, J. N. Medical College - KLE University, Nehru Nagar, Belgaum, Karnataka, India , Manvib, F. V. Department of Pharmaceutics - KLES College of Pharmacy - JNMC Campus, Nehru Nagar, Belgaum, Karnataka, India
Abstract :
A major hurdle in pharmaceutical formulation is water insolubility of most of drugs
affecting their stability and bioavailability. If the drug is also insoluble in organic
medium, it is difficult to deliver it in a sufficiently bioavailable form and hence it
is a great challenge to formulation researchers to overcome such difficulty. Although
some approaches are available for enhancing the dissolution of poorly soluble
drugs, there has been certain draw backs like use of organic solvents, low drug loading
and large doses. However, a new solution to poorly water soluble drug candidates
is now available, i.e. nanonisation that leads to much more soluble, more biologically
available and safer dosage form of poorly soluble and poorly bioavailable drugs.
Controlled release of these drugs is also possible by forming nanostructured
matrices. In this article, a brief description of production methods of drug
nanoparticles and commercialized methods are presented along with brief overview
on second generation of drug nanocrystal (Smart crystal technology), controlled
release of hydrophobic drugs and recent works thereof are also presented.
Keywords :
Bioavailability , Dissolution velocity , Insolubility , Saturation solubility , Smart crystal technology